Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $520,000 of MARSH & MCLENNAN COMPANIES INC. lobbying was just disclosed

None

$520,000 of MARSH & MCLENNAN COMPANIES INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Reauthorization of the National Flood Insurance Program, H.R. 9577, Community Based Catastrophe Insurance, H.R. 9056, Terrorism Risk Insurance Program, H.R. 7128 International and Corporate Tax Reform (H.R. 8101 & S.4221 "Ensuring Better Interest Treatment and Deductibility Act (EBITDA)"

You can find more data on corporate lobbying on Quiver Quantitative.

MRSH Insider Trading Activity

MRSH Insider Trades

MRSH insiders have traded $MRSH stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MRSH stock by insiders over the last 6 months:

  • JOHN Q DOYLE (President and CEO) has made 0 purchases and 2 sales selling 33,311 shares for an estimated $5,746,303.
  • NICHOLAS MARK STUDER (President and CEO of OWG) sold 3,837 shares for an estimated $706,122
  • JOHN JUDE JONES (Chief Marketing Officer) sold 2,362 shares for an estimated $410,067

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

MRSH Hedge Fund Activity

We have seen 648 institutional investors add shares of MRSH stock to their portfolio, and 702 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

MRSH Analyst Ratings

Wall Street analysts have issued reports on $MRSH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026

To track analyst ratings and price targets for MRSH, check out Quiver Quantitative's $MRSH forecast page.

MRSH Price Targets

Multiple analysts have issued price targets for $MRSH recently. We have seen 13 analysts offer price targets for $MRSH in the last 6 months, with a median target of $200.0.

Here are some recent targets:

  • Yaron Kinar from Mizuho set a target price of $197.0 on 07/09/2026
  • Ryan Tunis from Cantor Fitzgerald set a target price of $218.0 on 07/09/2026
  • Brian Meredith from UBS set a target price of $212.0 on 07/08/2026
  • Bob Huang from Morgan Stanley set a target price of $175.0 on 07/06/2026
  • Paul Newsome from Piper Sandler set a target price of $182.0 on 05/26/2026
  • Matthew Heimermann from Citigroup set a target price of $200.0 on 05/06/2026
  • Meyer Shields from Keefe, Bruyette & Woods set a target price of $203.0 on 04/17/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles